Wealth Science Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wealth Science Advisors's LLY Position: Q3 2026 in Review
Wealth Science Advisors reduced its Eli Lilly (LLY) stake by 18% in Q3 2026, selling an estimated $457K and leaving 1,777 shares worth $2.06M. The position accounts for 0.86% of the portfolio, ranked #21.
Wealth Science Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.6M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Wealth Science Advisors held 1,777 shares of Eli Lilly worth $2.06M as of Q3 2026.
- Wealth Science Advisors sold 387 Eli Lilly shares in Q3 2026, an estimated $457K.
- Eli Lilly made up 0.86% of Wealth Science Advisors's portfolio in Q3 2026, its #21 holding.
- Wealth Science Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Wealth Science Advisors's Eli Lilly position peaked at $2.6M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Wealth Science Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.